Cubed Biotech is a federally licensed psychedelic manufacturer developing both natural and novel therapeutic molecules, backed by proprietary IP such as a 99.66% pure natural psilocybin isolate and a non-hallucinogenic hybrid psychedelic pipeline. Their vertically integrated platform spans cultivation, synthetic chemistry, clinical-grade manufacturing, and university-validated research, positioning the company at the forefront of next-generation mental health treatment.